Organization · Venture Capital
Longwall Venture Partners LLP
Longwall Venture Partners LLP is a UK-based investment firm that focuses on early-stage deeptech companies in the healthcare, science, and engineering sectors. Founded in 2008, it leverages the UK's research expertise to address global challenges.
Overview
What Longwall Venture Partners LLP does
What Longwall Venture Partners LLP is
Longwall Venture Partners LLP is a UK-based investment firm that focuses on early-stage deeptech companies in the healthcare, science, and engineering sectors. Founded in 2008, it leverages the UK's research expertise to address global challenges.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Longwall Venture Partners LLP elsewhere
Open the official website or a supported primary organization account.
Capability profile
Longwall Venture Partners LLP as a funder
Investment thesis
Longwall Venture Partners LLP focuses on early-stage deeptech businesses that leverage the UK's expertise in science and research to address global challenges.
Focus narrative
Longwall Ventures invests in early-stage companies within the sectors of science, engineering, and health. Their investment strategy emphasizes businesses that not only have innovative technologies but also aim to create substantial positive impacts on society and the environment.
Value beyond capital
Longwall Ventures adds value to its portfolio companies through its strong connections with the Oxford University ecosystem, providing access to research, talent, and potential partnerships. The firm also offers strategic guidance and support in navigating the complexities of early-stage growth.
Terms and economics
- Typical check
- $1,000,000–$5,000,000
Focus and fit
- Stages
- Seed · Series A · Series B
- Sectors
- Biotech & Life SciencesHealthcareFrontier & Deep TechArtificial IntelligenceIndustrial & ManufacturingEnergyConsumer
- Regions
- United Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 36
- Recorded notable exits
- OrganOx
Portfolio context
Longwall Ventures has invested in notable companies such as OrganOx, which developed the world's first fully automated device for liver preservation, and was acquired for approximately $1.5B. Other portfolio highlights include Wayland Additive, Momentum Bioscience, and Lightcast Discovery, which focuses on single-cell analysis.
Common questions
What to know about Longwall Venture Partners LLP
Upseed classifies Longwall Venture Partners LLP under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.